pemivibart
NCCN Guidelines Recommend mAbs for COVID-19 PrEP in People With Cancer
NCCN Guidelines for the Prevention and Treatment of Cancer-Related Infections advise clinicians recommend mAbs to ...
AUGUST 4, 2025
Pemivibart Appears to Prevent COVID-19 Infection in CLL
Pemgarda is well tolerated and appears effective in preventing symptomatic COVID-19 infection among patients with ...
MAY 30, 2025
Pemivibart Continues Efficacy Against Circulating SARS-CoV-2 Strains
Recent in vitro neutralization data demonstrated the continued neutralizing activity of pemivibart (Pemgarda, ...
JANUARY 10, 2025
Long-Term Protection Against COVID-19 Seen With Pemivibart
Follow-up data from a phase 3 clinical trial show that pemivibart (Pemgarda, Invivyd) offers long-term protection ...
DECEMBER 19, 2024
Load more